Qepler | summits & conferences | 4th Annual Pharmaceutical Lyophilization Virtual Summit, 16-17 February 2023, ONLINE
Event Location:
Online Conference
Platform:
HOPIN
Date:
16 - 17 February 2023
Language:
English
Contact Person: Evgenia Makar
Contact Person: Evgenia Makar, Qepler s.r.o.
Contact Person: Denis Polikarpov
Contact Person: Denis Polikarpov, Qepler s.r.o.

Conference Overview

Although lyophilization is an old process, it remains to be complex. Today we can see increased trend in aseptic freeze-dried products, including biologics, APIs, nanomaterials and new devices. It makes the lyophilization cycle more complicated. Lyophilization becomes systematic and scientific process.

Pharmaceutical Lyophilization Summit 2022 is a knowledge sharing to showcase best practices in technical and regulatory updates, manufacturing and process development, freeze-dried formulation, testing, monitoring and new products development.

The featured talks on:

  • We need bigger crystals quo vadis controlled nucleation?
  • GMP-ready continuous freeze-drying of pharmaceuticals.
  • Freeze drying process design using a Design Space approach.
  • The influence of formulation in freeze drying biologics
  • Anatomy of the Lyophilization Process: Considerations for a Successful Tech Transfer.
  • Alternative Freeze Drying Technologies and Options for Process Intensification
  • Where’s the true sublimation end point in primary drying?
  • Impact of Elastomeric Closures on Freeze-dried Cakes.
  • How different vial concepts can help to avoid breakage due to freezing.
  • 4040/40 Elastomer Formulation Innovation for Lyo Application.

Meet our Speakers

PREVIOUS EVENT

SNAPSHOT OF ATTENDEES 2021

Applied Materials, Inc., USA - Aspen, ZA - Azbil Telstar Technologies SLU, ES - Baxter Healthcare, USA - Bayer AG, DE - Biopharma Group, UK - Boehringer Ingelheim, DE - Cambridge Design Partnership, UK - Catalent Biologics, USA - Catalent Pharma LLC, USA - Catalent Pharma Solutions , UK - Cenexi Lt sa, BE - Daiichi-Sankyo Europe GmbH, DE -Datwyler Pharma Packaging International NV, BE - De Montfort University, UK - Dr. Reddy's lab, IN - ELLAB A/S, DK - eTheRNA Immunotherapies NV, BE - Explicat Pharma GmbH, DE - Ferring GmbH, DE - Fresenius Kabi Oncology Ltd., IN - GEA Lyophil GmbH, DE - GSK, USA - Hemofarm, RS - Illumina, UK - Janssen, BE - Jazz Pharmaceuticals, CA - Laboratorio Reig Jofre, S.A., ES - LMU Munich, Pharmaceutical Technology and Biopharmacy, DE - Lyofal, FR - Lyomark Pharma GmbH, DE - Medichem Manufacturing (Malta) Limited, MT - Merck, USA - Merck KGaA, DE - Minapharm for pharmaceutical products, EG - NIBSC, UK - OPTIMA pharma GmbH, DE - Pfizer, BE - PharmaMar SA, ES - RAUMEDIC AG, DE - Sanofi-Aventis, FR - Sirton Pharmaceuticals SpA, IT - Takeda, AT - Tempris GmbH, DE - Terumo BCT, USA - University of Helsinki, FI - West Pharmaceutical Services, USA - World Health Organization, CH - Yuria-Pharm LLC, UA - and others.

Networking

Bram Jongen

Datwyler Pharma Packaging International NV

chaired a panel discussion with speakers from Shire, MSD, Bayer, Martin Christ, Boehringer Ingelheim, Ghent University, Lonza and De Montfort University.

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.